NASDAQ: KIDSOrthopediatrics Corp Stock
$18.16-0.71 (-3.76%)
Updated Jun 22, 2026
KIDS Price
$18.16
Fair Value Price
-$5.72
Market Cap
$466.44M
52 Week Low
$14.42
52 Week High
$23.70
P/E
-10.81x
P/B
1.38x
P/S
1.55x
PEG
N/A
Dividend Yield
N/A
Revenue
$243.30M
Earnings
-$39.68M
Gross Margin
73.1%
Operating Margin
-13.4%
Profit Margin
-16.3%
Debt to Equity
0.48
Operating Cash Flow
-$4M
Beta
1.23
Next Earnings
Aug 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A
KIDS Overview
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine KIDS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
KIDS
Ranked#67 of 93
Ranked#67 of 93
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.79 | A | |
| $38.40 | A | |
| $26.22 | A |
Be the first to know about important KIDS news, forecast changes, insider trades & much more!
KIDS News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how KIDS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
KIDS ($18.16) is overvalued by 417.31% relative to our estimate of its Fair Value price of -$5.72 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
KIDS ($18.16) is not significantly undervalued (417.31%) relative to our estimate of its Fair Value price of -$5.72 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
KIDS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more KIDS due diligence checks available for Premium users.
Valuation
KIDS fair value
Fair Value of KIDS stock based on Discounted Cash Flow (DCF)
Price
$18.16
Fair Value
-$5.72
Undervalued by
417.31%
KIDS ($18.16) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
KIDS ($18.16) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
KIDS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
KIDS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-10.81x
Industry
19.75x
Market
7.94x
KIDS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.38x
Industry
2.92x
KIDS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
KIDS's financial health
Profit margin
Revenue
$59.4M
Net Income
-$10.7M
Profit Margin
-18%
KIDS's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
KIDS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$502.2M
Liabilities
$163.5M
Debt to equity
0.48
KIDS's short-term assets ($245.87M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KIDS's short-term assets ($245.87M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KIDS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
KIDS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.3M
Investing
-$3.8M
Financing
-$614.0k
KIDS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
KIDS vs Medical Device Stocks
Orthopediatrics Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.